Axonopathy and cytoskeletal disruption in degenerative diseases of the central nervous system
Open accessAbstract
There has been growing interest in the axon as the initial focus of pathological change in a number of neurodegenerative diseases of the central nervous system. This review concentrates on three major neurodegenerative conditions--amyotrophic lateral sclerosis, multiple sclerosis and Alzheimer's disease--with emphasis on key cellular changes that may underlie early axonal dysfunction and pathology and, potentially, the degeneration of neurons. In particular, this review will address recent data that indicate that the main pathological stimuli for these conditions, though often not definitively determined, result in an initial perturbation of the axon and its cytoskeleton, which then results in slow neuronal degeneration and loss of connectivity. The identification of a degenerative process initiated in the axon may provide new therapeutic targets for early intervention to inhibit the grim outcomes related to the progression of these diseases.
Integrity signals
Registry
Cites
Statistics
Claims the paper makes
Claims other papers make about this one
Each is checked against this paper’s own text: does it say what the citing paper says it does?
The buildup of neurotoxic agents causes neuronal damage and death, which can lead to neurological dysfunction including cognitive decline, motor abnormalities, mental disorders, and loss of inhibition.
“The buildup of neurotoxic agents is believed to cause neuronal damage and death, which can ultimately lead to various forms of neurological dysfunction that include cognitive decline, motor abnormalities, mental disorders, and loss of inhibition (Chung et al., 2018; Taylor et al., 2002; Vickers et al., 2009).”
From SYK coordinates neuroprotective microglial responses in neurodegenerative disease (2022) · cites this paper as Vickers et al., 2009
The citation lists haven’t been fetched yet
References 108 · Cited by 69
- Authors
- Vickers, J. C., King, A. E., Woodhouse, A., Kirkcaldie, M. T., Staal, J. A., McCormack, G. H., Blizzard, C. A., Musgrove, R. E. J., Mitew, S., Liu, Y., Chuckowree, J. A., Bibari, O., & Dickson, T. C.
- Affiliations
- University of Tasmania (AU)
- Corresponding author
- Vickers, James C.
- ORCID
- Venue
- Brain Research Bulletin
- Publisher
- Elsevier BV
- Published
- 2009-10
- Volume
- 80
- Issue
- 4-5
- Pages
- 217-223
- ISSN
- 0361-9230 (ISSN-L)
- OpenAlex
- W2006223466
- Cited by
- 69
- References
- 108
- Citations by year
- 2025: 2 · 2024: 3 · 2023: 2 · 2022: 3 · 2021: 3 · 2020: 3 · 2019: 7 · 2018: 4 · 2017: 7 · 2016: 7 · 2015: 3 · 2014: 3 · 2013: 7 · 2012: 4
- FWCI
- 0.56
- Type
- journal article
- Language
- en
- Open access
- green
- figshare.com
- Locations
- Brain Research Bulletin (publishedVersion)
- PubMed (publishedVersion)
- eCite Digital Repository (University of Tasmania) (submittedVersion)
- Figshare (submittedVersion, cc-by)
- Topics
- Health Sciences › Medicine › Neurology › Amyotrophic Lateral Sclerosis Research
- Health Sciences › Medicine › Physiology › Alzheimer's disease research and treatments
- Life Sciences › Neuroscience › Cellular and Molecular Neuroscience › Hereditary Neurological Disorders
- Keywords
- axonopathy, axonal cytoskeleton, neurodegeneration, amyotrophic lateral sclerosis, multiple sclerosis, Alzheimer's disease, axonal dysfunction, central nervous system degenerative diseases, therapeutic target
- MeSH terms
- Alzheimer Disease, Amyotrophic Lateral Sclerosis, Axons, Cytoskeleton, Humans, Multiple Sclerosis
About these checks
Registry, retraction, Cites and statistics results are computed, not judged, with one exception: a printed reference that no index lists is read once by a model before it counts as a citation error. Claims are extracted by a model and kept only when their quote appears verbatim in the text; each cited source is then checked, with a model’s help, for whether it says what the claim relies on. Those verdicts can be wrong — read the claim’s quote and the cited source before relying on one.
Statistics and arithmetic are recomputed, not judged.
Confidence bands are shown only for fields calibrated on our annotated test set. None is calibrated yet, so no band is shown.
What counts as a claim ›How we measure confidence ›How we check this ›
Are you an author, or do you see a problem with this page? Request a review